Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15.
about
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 systemInterleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor geneIL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcomaToxin-based targeted therapy for malignant brain tumorsCharacterization of the cytoplasmic domain of interleukin-13 receptor-alphaCharacterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activationCharacterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytesCombining cytotoxic and immune-mediated gene therapy to treat brain tumorsA modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor.Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptorCytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression.Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblastsMucosal immunity against parasitic gastrointestinal nematodesKinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.Induction of uteroglobin-related protein 2 (Ugrp2) gene expression by the Th2 cytokines IL-4 and IL-13.Interleukin-4 and interleukin-13: their similarities and discrepancies.STAT6⁻/⁻ mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis.Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumoniaThe involvement of interleukin-1 and interleukin-4 in the response of human annulus fibrosus cells to cyclic tensile strain: an altered mechanotransduction pathway with degenerationBiology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma.Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblastsHodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal modelRegulation of inflammation by interleukin-4: a review of "alternatives"In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice.Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma.Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity.Structural biology of shared cytokine receptors.IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain.Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model.IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function.Transgenic modelling of cytokine polarization in the lung.The potential for genetically altered microglia to influence glioma treatment.Multifarious determinants of cytokine receptor signaling specificity.Interleukin-13 and its receptors in colorectal cancer (Review).Regulation of interleukin-13 receptor constituents on mature human B lymphocytes.IL-13 upregulates GPIIb expression in megakaryocytic cell lines via STAT6.
P2860
Q24310081-00970602-F2B7-498E-88B9-FF22205289CEQ24324698-FD043480-096A-479F-B6AC-CB1CC2875346Q24601302-97A33C87-A51E-4C65-B447-D5ADA47480EAQ27006226-C87222BB-00D9-4F4D-B3B9-0ABB7B978DB4Q28139906-39A60285-8795-4080-9869-FD46DED3185CQ28142632-5250A9DE-66B3-4386-836A-0DE1C7EF0F70Q28208081-7550C610-DBB4-478C-896C-A7C87265D2D2Q28289279-D92C6A4E-1B65-453A-A205-4476F861F05CQ31013320-CE8A0B20-D4ED-413B-AD28-B70234620EE0Q33241201-D161CDFA-03F2-4BEF-A6A7-5D0CD77AEBC1Q33633115-7A5259EF-E283-4633-976B-23E5873A96DAQ33784084-1F101570-1536-48BA-BDC9-AC04CF349559Q34020430-DACD82C8-4958-47AD-90FA-C442AF082142Q34118373-F996BDF2-EB29-4A45-89C9-6E73A10B4975Q34170802-A29E0F99-1EE8-41C8-8084-4D632363228AQ34345121-694ED38C-8024-46A1-BDAF-D76909042D6EQ34488885-519050F4-B1B6-4FEE-9ABA-4092239FAA49Q34776805-16B5D00D-E987-4217-AF08-E75F4E2BA06AQ35098429-5BF0BBB6-C436-457B-A0CD-37ECF2B933B9Q35620281-75EF5681-54C0-47E6-BA7B-75BDF4FE87DEQ35627845-650CDCAC-75F0-4FBC-9960-921857FDB3C4Q35749147-37EEE623-EB10-4023-AF4D-2DD3B4FD0C11Q35847498-1CF6858D-A871-4FDD-A020-E81519D0F1B2Q36232198-1ADFF021-CC13-4A92-AA7B-B1107947F1DCQ36369794-778FEE71-1F17-446E-BF3E-CC2500146DF6Q36437751-8D89B8F6-ECCE-4BC0-9079-48319CF2A198Q36478656-2BBACBB6-BBCA-4186-8B19-8FB1E5A6473FQ36871712-F9172347-6C7D-41D2-BCFE-24E36C92069CQ36926747-C74328A4-A29F-4E97-BBED-87E00DB0EAF3Q36946566-9E215979-8651-4F63-A254-8EED85F83925Q37279324-0AA3A6F4-C92D-4AA6-8004-CD421033C913Q37358006-29EA6D5F-D565-40D9-8275-C8B05FB2984CQ37372980-95BAA449-6D55-4EF4-898A-9495D924220CQ37647886-E15C6621-D6C6-4940-A2BF-4F17014BEA62Q37811063-B3110B15-61E8-42EF-8F55-6EA4FC9EDCE2Q38139120-530687FD-5487-4BDA-B7D5-C7FA00F5DED0Q38175584-2466D362-1FC0-4C76-B8C5-D449A63FF4B6Q38197617-8E92B4E5-16F6-4C37-9351-BC56FFBD2D2DQ38337458-A66F7399-5029-44A2-AB97-1B9DFE3C8B72Q39676834-5BFFB005-799B-4043-8A77-083D5D70D851
P2860
Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Receptor for interleukin 13. I ...... terleukins 2, 4, 7, 9, and 15.
@en
Receptor for interleukin 13. I ...... terleukins 2, 4, 7, 9, and 15.
@nl
type
label
Receptor for interleukin 13. I ...... terleukins 2, 4, 7, 9, and 15.
@en
Receptor for interleukin 13. I ...... terleukins 2, 4, 7, 9, and 15.
@nl
prefLabel
Receptor for interleukin 13. I ...... terleukins 2, 4, 7, 9, and 15.
@en
Receptor for interleukin 13. I ...... terleukins 2, 4, 7, 9, and 15.
@nl
P2093
P2860
P356
P1476
Receptor for interleukin 13. I ...... terleukins 2, 4, 7, 9, and 15.
@en
P2093
P2860
P304
P356
10.1074/JBC.270.15.8797
P407
P577
1995-04-01T00:00:00Z